Open access
Aug 2026
SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry
Results provide a clear experimental validation proof that microbial epitopes mimicking TAAs can be used to develop off-the-shelf preventive/therapeutic vaccine formulations.
Concetta Ragone, Angela Mauriello, Beatrice Cavalluzzo et al.
· Journal of Translational Med... · 0 citations